Molnupiravir (development codes MK-4482 and EIDD-2801) is an experimental antiviral drug which is orally active (can be taken orally) and was developed for the treatment of influenza.
Against coronaviruses including SARS, MERS, SARS-CoV-2 and Covid19.
蘇州正永生物醫(yī)藥有限公司
聯(lián)系商家時請?zhí)峒癱hemicalbook,有助于交易順利完成!
正永生物